Přihlásit se Zaregistrujte se zdarma

Quick ratio společnosti Alexion Pharmaceuticals

Jaká je hodnota metriky Quick ratio společnosti Alexion Pharmaceuticals?

Hodnota metriky Quick ratio společnosti Alexion Pharmaceuticals Inc. je 3.47

Jaká je definice metriky Quick ratio?



Quick ratio je ukazatel likvidity, který měří schopnost společnosti využít své jmění na pokrytí krátkodobých závazků.

The quick ratio is the ratio between quick or liquid assets and current liabilities. Quick assets include those current assets that presumably can be quickly converted to cash at close to their book values. A normal liquid ratio is considered to be 1. A company with a quick ratio of less than 1 cannot at the time fully pay its current liabilities or short-term obligations. This ratio is considered to be a much reliable tool for assessment of liquidity position of companies.

Quick ratio společností v sektoru Health Care sektor na NASDAQ ve srovnání se společností Alexion Pharmaceuticals

Čemu se věnuje společnost Alexion Pharmaceuticals?

Alexion is a global biopharmaceutical company focused on serving patients and families affected by rare diseases and devastating conditions through the discovery, development and commercialization of life-changing medicines. As a leader in rare diseases for more than 25 years, Alexion has developed and commercializes two approved complement inhibitors to treat patients with paroxysmal nocturnal hemoglobinuria (PNH) and atypical hemolytic uremic syndrome (aHUS), as well as the first and only approved complement inhibitor to treat anti-acetylcholine receptor (AchR) antibody-positive generalized myasthenia gravis (gMG) and neuromyelitis optica spectrum disorder (NMOSD). Alexion also has two highly innovative enzyme replacement therapies for patients with life-threatening and ultra-rare metabolic disorders, hypophosphatasia (HPP) and lysosomal acid lipase deficiency (LAL-D) as well as the first and only approved Factor Xa inhibitor reversal agent. In addition, the company is developing several mid-to-late-stage therapies, including a copper-binding agent for Wilson disease, an anti-neonatal Fc receptor (FcRn) antibody for rare Immunoglobulin G (IgG)-mediated diseases and an oral Factor D inhibitor as well as several early-stage therapies, including one for light chain (AL) amyloidosis, a second oral Factor D inhibitor and a third complement inhibitor. Alexion focuses its research efforts on novel molecules and targets in the complement cascade and its development efforts on hematology, nephrology, neurology, metabolic disorders, cardiology, ophthalmology and acute care. Headquartered in Boston, Massachusetts, Alexion has offices around the globe and serves patients in more than 50 countries.

Firmy s metrikou quick ratio podobnou společnosti Alexion Pharmaceuticals



  • Hodnota metriky Quick ratio společnosti Trevena Inc je 3.46
  • Hodnota metriky Quick ratio společnosti Aquis Exchange PLC je 3.46
  • Hodnota metriky Quick ratio společnosti Inventiva SA je 3.46
  • Hodnota metriky Quick ratio společnosti Lynas je 3.46
  • Hodnota metriky Quick ratio společnosti Lynas je 3.46
  • Hodnota metriky Quick ratio společnosti DermTech je 3.46
  • Hodnota metriky Quick ratio společnosti Alexion Pharmaceuticals je 3.47
  • Hodnota metriky Quick ratio společnosti Sing Tao News je 3.47
  • Hodnota metriky Quick ratio společnosti Castlecap Capital je 3.47
  • Hodnota metriky Quick ratio společnosti MBIA je 3.47
  • Hodnota metriky Quick ratio společnosti Wim Plast je 3.47
  • Hodnota metriky Quick ratio společnosti SNL Bearings je 3.47
  • Hodnota metriky Quick ratio společnosti Scienjoy je 3.47